11 September 1986
1 April 1986
COMMERCIAL ITEM DESCRIPTION
MAGALDRATE ORAL SUSPENSION, USP
The General Services Administration has authorized the use of this Commercial Item Description.
Shall be a palatable pleasantly-flavored Magaldrate Oral Suspension, USP.
Shall be in accordance with the requirements of the USP.
Shall contain 540 mg of Magaldrate per 5 ml of suspension within the applicable assay limits of the suspension.
Workmanship. suspension shall be free from defects which detract from its appearance or impair its serviceability.
Unit. Bottle (BT). One bottle containing 12 fl oz (355 ml), as specified, constitutes one unit.
Contractor certification. The contractor shall certify and maintain substantiating evidence that the product offered meets the salient characteristics of this Commercial Item Description, and that the product conforms to the producersí own drawings, specifications, standards, and quality assurance practices. The government reserves the right to require proof of such conformance prior to first delivery and thereafter as may be otherwise provided for under the provisions of the contract.
DISTRIBUTION STATEMENT A: Approved for public release; distribution is unlimited.
For Parts Inquires submit RFQ to Parts Hangar, Inc.
© Copyright 2015 Integrated Publishing, Inc.
A Service Disabled Veteran Owned Small Business